Literature DB >> 15305037

Role of Ca2+/calmodulin signaling pathway on morphological development of Candida albicans.

Tatsuki Sato1, Yukihiro Ueno, Toshihiko Watanabe, Takeshi Mikami, Tatsuji Matsumoto.   

Abstract

A human fungal pathogen, Candida albicans, varies from the yeast form to the hyphal form due to various external signals. This morphogenetic transformation has been implicated in the development of pathogenicity. In this report, we show that calmodulin inhibitors (TFP and W-7) and an adenylatecyclase inhibitor (MDL-12-330A) suppressed the hyphae formation of C. albicans. Furthermore, the expression of hyphae-specific mRNAs located downstream from the RAS1-cAMP pathway was inhibited by these inhibitors. Suppression of hyphae formation by TFP or W-7 was not inhibited by the addition of cAMP, and these inhibitors did not affect the amount of cAMP in C. albicans. These results suggest that the Ca2+/calmodulin pathway contributes to hyphae formation and is related to the RAS1-cAMP pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305037     DOI: 10.1248/bpb.27.1281

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  11 in total

1.  Transcriptional effect of a calmodulin inhibitor, W-7, on the ligninolytic enzyme genes in Phanerochaete chrysosporium.

Authors:  Takaiku Sakamoto; Hironori Kitaura; Masahiko Minami; Yoichi Honda; Takashi Watanabe; Akio Ueda; Kazumi Suzuki; Toshikazu Irie
Journal:  Curr Genet       Date:  2010-06-09       Impact factor: 3.886

2.  Effects of calmodulin on expression of lignin-modifying enzymes in Pleurotus ostreatus.

Authors:  Takashi Suetomi; Takaiku Sakamoto; Yoshitaka Tokunaga; Toru Kameyama; Yoichi Honda; Hisatoshi Kamitsuji; Isamu Kameshita; Kousuke Izumitsu; Kazumi Suzuki; Toshikazu Irie
Journal:  Curr Genet       Date:  2014-11-19       Impact factor: 3.886

Review 3.  Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.

Authors:  Xiuyun Li; Yinglong Hou; Longtao Yue; Shuyuan Liu; Juan Du; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

4.  Roles of Cch1 and Mid1 in morphogenesis, oxidative stress response and virulence in Candida albicans.

Authors:  Qilin Yu; Hui Wang; Xinxin Cheng; Ning Xu; Xiaohui Ding; Laijun Xing; Mingchun Li
Journal:  Mycopathologia       Date:  2012-08-12       Impact factor: 2.574

5.  Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction.

Authors:  Bessie W Kebaara; Melanie L Langford; Dhammika H M L P Navarathna; Raluca Dumitru; Kenneth W Nickerson; Audrey L Atkin
Journal:  Eukaryot Cell       Date:  2008-04-18

6.  Calcium/calmodulin kinase1 and its relation to thermotolerance and HSP90 in Sporothrix schenckii: an RNAi and yeast two-hybrid study.

Authors:  Jorge Rodriguez-Caban; Waleska Gonzalez-Velazquez; Lizaida Perez-Sanchez; Ricardo Gonzalez-Mendez; Nuri Rodriguez-del Valle
Journal:  BMC Microbiol       Date:  2011-07-11       Impact factor: 3.605

7.  A calmodulin inhibitor, W-7 influences the effect of cyclic adenosine 3', 5'-monophosphate signaling on ligninolytic enzyme gene expression in Phanerochaete chrysosporium.

Authors:  Takaiku Sakamoto; Yuki Yao; Yoshifumi Hida; Yoichi Honda; Takashi Watanabe; Wataru Hashigaya; Kazumi Suzuki; Toshikazu Irie
Journal:  AMB Express       Date:  2012-01-24       Impact factor: 3.298

8.  Calmodulin binding to Dfi1p promotes invasiveness of Candida albicans.

Authors:  Talya R Davis; Paola C Zucchi; Carol A Kumamoto
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  Current awareness on yeast.

Authors: 
Journal:  Yeast       Date:  2005-01-30       Impact factor: 3.239

10.  Functional, genetic and bioinformatic characterization of a calcium/calmodulin kinase gene in Sporothrix schenckii.

Authors:  Liz Valle-Aviles; Shirley Valentin-Berrios; Ricardo R Gonzalez-Mendez; Nuri Rodriguez-Del Valle
Journal:  BMC Microbiol       Date:  2007-11-29       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.